Advisors Capital Management LLC Purchases 339 Shares of STERIS plc $STE

Advisors Capital Management LLC increased its position in shares of STERIS plc (NYSE:STE) by 11.1% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 3,404 shares of the medical equipment provider’s stock after purchasing an additional 339 shares during the quarter. Advisors Capital Management LLC’s holdings in STERIS were worth $818,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Allworth Financial LP boosted its stake in shares of STERIS by 7.3% in the 2nd quarter. Allworth Financial LP now owns 661 shares of the medical equipment provider’s stock worth $159,000 after buying an additional 45 shares during the last quarter. Ashton Thomas Private Wealth LLC boosted its position in STERIS by 3.5% in the first quarter. Ashton Thomas Private Wealth LLC now owns 1,611 shares of the medical equipment provider’s stock worth $365,000 after purchasing an additional 54 shares during the last quarter. Cetera Investment Advisers grew its stake in STERIS by 0.9% in the 1st quarter. Cetera Investment Advisers now owns 6,999 shares of the medical equipment provider’s stock valued at $1,586,000 after purchasing an additional 63 shares during the period. Horizon Investments LLC grew its stake in STERIS by 4.7% in the 1st quarter. Horizon Investments LLC now owns 1,410 shares of the medical equipment provider’s stock valued at $320,000 after purchasing an additional 63 shares during the period. Finally, Alliance Wealth Advisors LLC UT increased its position in shares of STERIS by 2.0% during the 1st quarter. Alliance Wealth Advisors LLC UT now owns 3,305 shares of the medical equipment provider’s stock valued at $749,000 after purchasing an additional 64 shares during the last quarter. Hedge funds and other institutional investors own 94.69% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on STE. Weiss Ratings reissued a “buy (b)” rating on shares of STERIS in a report on Tuesday, October 14th. Morgan Stanley boosted their target price on shares of STERIS from $276.00 to $295.00 and gave the company an “overweight” rating in a research note on Friday, August 8th. Wall Street Zen upgraded shares of STERIS from a “buy” rating to a “strong-buy” rating in a research note on Sunday, September 14th. Finally, KeyCorp lifted their price target on shares of STERIS from $277.00 to $288.00 and gave the stock an “overweight” rating in a report on Tuesday, July 22nd. Seven research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $273.50.

STERIS Stock Down 0.6%

STE stock opened at $258.75 on Friday. The stock has a 50-day simple moving average of $245.98 and a two-hundred day simple moving average of $240.35. STERIS plc has a twelve month low of $200.98 and a twelve month high of $268.30. The firm has a market capitalization of $25.40 billion, a PE ratio of 39.62 and a beta of 1.02. The company has a quick ratio of 1.53, a current ratio of 2.22 and a debt-to-equity ratio of 0.27.

STERIS (NYSE:STE) last issued its quarterly earnings data on Wednesday, November 5th. The medical equipment provider reported $2.47 EPS for the quarter, beating the consensus estimate of $2.38 by $0.09. STERIS had a net margin of 11.61% and a return on equity of 14.17%. The company had revenue of $1.46 billion during the quarter, compared to analysts’ expectations of $1.43 billion. During the same quarter in the previous year, the company earned $2.14 earnings per share. STERIS has set its FY 2026 guidance at 10.150-10.30 EPS. On average, equities analysts predict that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, December 18th. Shareholders of record on Tuesday, November 18th will be paid a $0.63 dividend. The ex-dividend date of this dividend is Tuesday, November 18th. This represents a $2.52 annualized dividend and a yield of 1.0%. STERIS’s dividend payout ratio is currently 36.21%.

Insiders Place Their Bets

In related news, CEO Daniel A. Carestio sold 159 shares of STERIS stock in a transaction on Monday, October 6th. The shares were sold at an average price of $241.82, for a total value of $38,449.38. Following the transaction, the chief executive officer owned 51,096 shares in the company, valued at $12,356,034.72. This trade represents a 0.31% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, VP John Adam Zangerle sold 15,000 shares of the business’s stock in a transaction on Tuesday, November 11th. The stock was sold at an average price of $265.14, for a total transaction of $3,977,100.00. Following the completion of the sale, the vice president directly owned 33,669 shares of the company’s stock, valued at $8,926,998.66. This represents a 30.82% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 18,363 shares of company stock valued at $4,814,114. 1.07% of the stock is currently owned by corporate insiders.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.